Chronic graft-versus-host disease (cGVHD) is a complex, multisystem condition that can be challenging to recognize, assess, and manage, and is associated with significant morbidity and long-term health impacts. Recent advances in transplant practices and targeted immunomodulatory therapies have expanded options for individualized, organ-specific care. Comprehensive management requires early risk assessment, patient education, clear multidisciplinary communication, treatment selection aligned with consensus guidelines, and thoughtful integration of emerging clinical evidence.

Explore different topics within the portal to learn more about guideline-based approaches to diagnosing and treating cGVHD, evolving therapeutic strategies, and supportive care considerations across affected organ systems.